--HC Wainwright Initiates Magenta Therapeutics at Neutral
9:37AM ET 2/28/2023 MT Newswires(MT Newswires covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may...
(MT Newswires covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may...
US equities were set to open in red territory Friday, with futures of the technology-heavy Nasdaq Composite leading the losses following lackluster...
Genetic Technologies (GENE) shares soared 171% after detailing plans to launch a simple saliva-based test kit to evaluate a women's risk of developing...
(MT Newswires covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may...
(MT Newswires covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may...
Ocuphire Pharma (OCUP) shares dropped 26%, a day after the company said the phase 2 trial of its oral diabetic retinopathy drug candidate did not meet the...
Wedbush downgrades Magenta Therapeutics (MGTA) to neutral from outperform after the company decided to pause its dose escalation study of MGTA-117 in...
(MT Newswires covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may...
Entrada Therapeutics (TRDA) shares plunged Tuesday after yesterday saying the US Food and Drug Administration placed a clinical hold on the investigational...
Magenta Therapeutics (MGTA) said Tuesday it will not dose participants at the group four dosing level for its MGTA-117 phase 1/2 dose escalation trial in...